Table 1.
Anatomical Structure | Neurotransmitters, Neurochemicals or Receptors | Modulatory Effect on Transduction or Transmission (F: Facilitation; I: Inhibition | Examples of modulating Drugs (Inhibit facilitation or enhance inhibition of pain transduction or transmission) |
---|---|---|---|
| |||
Peripheral Nervous System PAN Terminal | Leukotriene Prostaglandins Potassium Histamine Bradykinin Serotonin Substance P Endorphin |
Transduction F, sensitizes F, sensitizes F, sensitizes F, sensitizes F, sensitizes F, sensitizes F, sensitizes I |
corticosteroids, ketoprofen NSAIDs, e.g., ASA n/a antihistamines n/a n/a n/a opioids |
Fiber | Na+, K+exchange across the cellular membrane | F, Transmission of action potential to CNS | mexiletine, tocainide, EMLA |
| |||
Autonomic Nervous System | Norepinephrine |
Transduction F, sensitizes nociceptive state F, activates neuropathic state |
anxiolytics |
| |||
Spinal Cord | Substance P, glutamate, and others serotonin (5HT1B and 5HT3) norepinephrine mu delta kappa GABAA GABAB |
F, Transmission to projection cell (2nd order neuron) F, Transmission with wind-up |
opioids ketamine dextromethorphan TCAs TCAs, clonidine opioid agonists (e.g. morphine) opioid agonists opioid antagonist-agonists benzodiazepines baclofen |
| |||
Brain | Substance P, glutamate, and others | F, Transmission to 3rd or 4th order neuron | opioids |
Key: PAN=primary afferent nociceptor; ASA=aspirin; NSAIDs=nonsteroidal antiinflammatory drugs; n/a=not available or not applicable; Na+=sodium; K+=potassium; CNS=central nervous system; TCAs=tricyclic antidepressant drugs or other re-uptake inhibitor drugs. © 2001 D.J. Wilkie, used with permission.